Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Pisansky

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyBruce D Minsky, Thomas F Pajak, Robert J Ginsberg, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate CancerKimberly R Gergelis, Miao Bai, Jiasen Ma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancerWilliam G Breen, Bradley J Stish, William S Harmsen, et al.
Brachytherapy|September 18, 2004
Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithmBrian J Davis, Debra H Brinkmann, Jon J Kruse, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysisJohnny Ray Bernard, Steven J Buskirk, Michael G Heckman, et al.
Cancer Journal (Sudbury, Mass.)|February 11, 2005
Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppressionMatthew C Solhjem, Brian J Davis, Thomas M Pisansky, et al.
Cancer Medicine|September 15, 2020
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancerMiao Bai, Kimberly R Gergelis, Mustafa Sir, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapyMatthew C Solhjem, Brian J Davis, Thomas M Pisansky, et al.
Brachytherapy|April 6, 2004
Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapyDavid J Schwartz, Brian J Davis, Richard J Vetter, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05Steven J Feigenberg, W Robert Lee, Michelle L Desilvio, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyBruce D Minsky, Thomas F Pajak, Robert J Ginsberg, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate CancerKimberly R Gergelis, Miao Bai, Jiasen Ma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancerWilliam G Breen, Bradley J Stish, William S Harmsen, et al.
Brachytherapy|September 18, 2004
Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithmBrian J Davis, Debra H Brinkmann, Jon J Kruse, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysisJohnny Ray Bernard, Steven J Buskirk, Michael G Heckman, et al.
Cancer Journal (Sudbury, Mass.)|February 11, 2005
Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppressionMatthew C Solhjem, Brian J Davis, Thomas M Pisansky, et al.
Cancer Medicine|September 15, 2020
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancerMiao Bai, Kimberly R Gergelis, Mustafa Sir, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapyMatthew C Solhjem, Brian J Davis, Thomas M Pisansky, et al.
Brachytherapy|April 6, 2004
Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapyDavid J Schwartz, Brian J Davis, Richard J Vetter, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05Steven J Feigenberg, W Robert Lee, Michelle L Desilvio, et al.
Pageof 14